Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: Single-center Phase I/II Trial of Sodium Oxybate in Patients With Alternating Hemiplegia of Childhood (AHC-SO Trial)
Brief Summary:
WHO: The investigators are recruiting children and young adults to participate in a research study who:
WHY: The goal of this study is to evaluate whether the study drug can safely and effectively decrease AHC episodes and improve the quality of life of individuals with AHC.
WHAT and WHERE: This study involves at least 12 weeks of completing and submitting daily AHC Episode Logs and a five-day hospital stay at the University of Utah CCTS.
There are 4 phases of the study, and they include:
COMPENSATION:
There is no fee to participate. All procedures performed specifically for this study will be covered by the study and will not be billed to you or your insurance company.